Jeffrey P. Nadler

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

Roy M. Gulick, Jacob Lalezari, James Goodrich et al. · New England Journal of Medicine · 2008 · 735 citations · Full text

Efficacy of Pneumococcal Vaccine in High-Risk Patients

Michael S. Simberkoff, Anne Cross, Mohamed Al‐Ibrahim et al. · New England Journal of Medicine · 1986 · 400 citations

Vaccination, Vaccine Safety, Pneumococcal Vaccine +10

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy

Calvin Cohen, Susan C. Hunt, Michael Sension et al. · AIDS · 2002 · 197 citations

Immunologic and Virologic Effects of Subcutaneous Interleukin 2 in Combination With Antiretroviral Therapy

Richard T. Davey, Robert L. Murphy, Andrew T. Pavia et al. · JAMA · 2000 · 174 citations

The NEAT Study: A 48-Week Open-Label Study to Compare the Antiviral Efficacy and Safety of GW433908 Versus Nelfinavir in Antiretroviral Therapy???Naive HIV-1-Infected Patients

A Rodriguez‐French, Jack Boghossian, Glenda Gray et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2003 · 150 citations